US Patent 7385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Barbara Jagodzinska0
Gary Probst0
Jay Tung0
Jose Aquino0
Michel Maillard0
Varghese John0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors US Patent 7385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
Infobox
Patent Number
073850850
Patent Number
73850850
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073850850
Date of Patent
June 10, 2008
0Patent Application Number
111773240
Date Filed
July 11, 2005
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
Infobox
Is a
Patent jurisdiction
Patent number
07385085
Date of patent
June 10, 2008
Patent application number
11177324
Date Filed
July 11, 2005
Patent primary examiner
Find more entities like US Patent 7385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
